Industry
Medical - Devices
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
August 02, 2024 | 6:36 pm
Portfolio Pulse from Benzinga Insights
August 02, 2024 | 2:00 pm
Portfolio Pulse from Benzinga Newsdesk
August 02, 2024 | 1:16 pm
Portfolio Pulse from Benzinga Newsdesk
August 01, 2024 | 9:44 pm
Portfolio Pulse from Benzinga Newsdesk
August 01, 2024 | 8:27 pm
Portfolio Pulse from Benzinga Insights
July 16, 2024 | 8:01 pm
Portfolio Pulse from Benzinga Newsdesk
July 16, 2024 | 1:55 pm
Portfolio Pulse from Benzinga Newsdesk
June 17, 2024 | 8:07 pm
Portfolio Pulse from Benzinga Insights
May 06, 2024 | 5:00 pm
Portfolio Pulse from Benzinga Newsdesk
May 06, 2024 | 4:00 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.